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ABSTRACT
Introductions: Clinical diagnosis of chronic obstructive pulmonary disease is 
often not accurate and treated for prolong duration. This study explores the use 
of pulmonary function test to confirm the diagnosis and further management 
of such patients. 
Methods: This was a cross sectional study conducted at Patan Hospital, Patan 
Academy of Health Sciences, Nepal. All patients coming for spirometry between 
June 2012 and May 2013 with the clinical diagnosis of chronic obstructive 
pulmonary disease were enrolled in the study. 
Results: Out of 338 patients with clinical diagnosis of chronic obstructive 
pulmonary disease that underwent spirometry, 80 (23.7%) patients had ratio of 
forced expiratory volume in one second and forced vital capacity less than 70%. 
Out of these 80 patients, 50 (14.8%) had irreversible airway obstruction and 
30 (8.9%) had reversible airway obstruction. Patient with normal spirometry 
findings was 258(76.3%).
Conclusions: Clinically diagnosed chronic obstructive pulmonary disease is 
best confirmed  by spirometry for optimum management.
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Plain Language Summary 
The study was done to see whether the clinical diagnosis of COPD is accurate of 
not. The study found that most of the patient diagnosed as COPD did not have the 
disease on spirometry. So, diagnosis of COPD should always be aided by spirometry 
before starting long term treatment.
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INTRODUCTIONS
According to 2008 Global initiative for chronic lung 
disease update, clinical diagnosis of Chronic Obstructive 
Pulmonary Disease (COPD) should be considered in any 
patient who has dyspnoea, chronic cough or sputum 
production, or a history of smoking.  The diagnosis of 
COPD should be confirmed by spirometry.1 A cohort in 
20052 and 20063 showed that almost half of the patients 
diagnosed to be COPD clinically did not have the disease.
This study was designed to see the pulmonary function by 
spirometry for patients diagnosed clinically with COPD.
METHODS
This was a descriptive cross sectional study evaluating 
records of patients with COPD coming for spirometry at 
pulmonary function test unit of Patan Hospital, Patan 
Academy of Health Sciences (PAHS), Nepal between 
June 2012 and May 2013. These patients were clinically 
diagnosed as COPD in outpatient department of general 
practice and medical department. Ethical approval 
was taken from the institutional review committee of 
PAHS. Records of all patients consecutively registered 
at pulmonary function test unit were analyzed. 
Spriometry diagnosis of COPD was defined as ratio of 
forced expiratory volume in one second and forced vital 
capacity (FEV1/FVC) less than 0.70 and reversibility as 
post bronchodilator change in forced expiratory volume 
in one second (FEV1) more than 0.20 of predicted. 
Microsoft Access 2007 was used to record data and 
statistical analysis was done using SPSS 16.0.  Student’s 
t-test and chi square test were used, p value < 0.05 was 
taken as statistically significant.
RESULTS
Out of 409 patients referred for spirometry, 338 patients 
with clinical diagnosis of COPD were evaluated while 
69 patients with other diagnoses like bronchial asthma, 
pneumonia were excluded from the study. Out of 338 
study patients, 174 (51.5%) were male and 164 (41.5%) 
female. Mean age was 62.7 years, range 37 to 88 years. 
Smokers were 291 (86.1%) and non smokers 47 (39.9%).
Out of 338 clinically diagnosed COPD patients, 80 
(23.7%) had FEV1/FVC ratio less than 70% while 258 
(76.3%) patients had FEV1/FVC ratio more than 70%. 
Out of these 80 patients, 50 (14.8%) had irreversible 
airway obstruction and 30 (8.9%) had reversible airway 
obstruction. Mean FEV1/FVC, FEV1 and FVC of patients 
with irreversible airway obstruction was 59.7%, 41.4% 
70.0% respectively of predicted values, those with 
reversible airway obstruction had 59.7%, 55.04%, 65.3% 
respectively of predicted values and those who did not 
require bronchodilator had 94.2%, 59.1% and 63.1% 
respectively of predicted values. The differences observed 
in these three groups were statistically significant for 
FEV1/FVC (p<0.05), FEV1 (p<0.05) and insignificant for 
FVC (p=0.1). Similarly in male mean FEV1/FVC, FEV1 and 
FVC were 86.02%, 50.6%, 59.7% respectively of predicted 
and in female 86.1%, 59.7% and 71.1% of respectively 
of predicted values. The difference in values for male 
and female was statistically not significant for FEV1/FVC 
(p<=0.9), FVC (p=0.9) and significant for FEV1 (p=0.02). 
On evaluation with non smoking status the values were 
98.4%, 62.1%, 65.04% respectively of predicted values 
and with smoker it was 84.07%, 53.8% and 66.3% 
respectively of predicted values. The difference in smoker 
and nonsmoker was statistically significant for FEV1/FVC 
(p<0.05), FEV1 (p=0.02) and insignificant for FVC (p=0.9).
Table 1. Difference in spirometry results in clinically diagnosed COPD 
patients (n=338) in relation to gender
Gender PFT Diagnosis FEV1/FVC % * FEV1 % † FVC % ‡
Female
Irreversible airway obstruction 59.5 37.7 69.9
Reversible airway obstruction 59.7 37.02 63.3
Normal § 93.6 54.4 58.6
Male
Irreversible airway obstruction 59.8 44.5 75.3
Reversible airway obstruction 94.8 64.3 68.1
Normal § 94.8 64.3 68.1
* p<0.9; † p<0.05; ‡ p<0.05; § Reversibility not checked
Figure 1. Frequency distribution in different age group in clinically 
diagnosed COPD patients (n=338)
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Table 2. Difference in spirometry results in clinically diagnosed COPD 










Irreversible airway obstruction 59.7 41.0 69.4
Reversible airway obstruction 59.0 43.7 78.2
Normal* 92.6 58.0 62.8
Non 
Smoker
Irreversible airway obstruction 85.7 50.9 59.3
Reversible airway obstruction 51.7 28.1 66.0
Normal* 65.0 65.08 102.5
* p<0.05; † p=0.02; ‡ p<0.09; § Reversibility not checked
Evaluation of different age group and pulmonary function 
test showed no statistically significant difference on age 
category with respect to pulmonary function test results 
(FEV1/FVC: p=0.3, FEV1: p=0.09 and FVC: p=0.9).
DISCUSSIONS
Global initiative to prevent lung disease recommends 
spirometry for the diagnosis of COPD.1 However, 
spirometry is underutilized in many parts of the world. 
In a study done in US, it was found that spirometry use 
was 66% in pediatricians, 47% in family practitioners 
and 60% in internal medicine.4 Another study in Nigeria 
stated that knowledge and practice of spirometry were 
poor among hospital based Nigerian doctors because of 
unavailability of spirometry in most hospitals.5 We found 
that 258 (76.3%)  patients with clinical diagnosis of COPD 
had normal pulmonary function test result. This shows 
mismatch between clinical diagnosis and spirometry 
findings. To minimize unnecessary load and misuse of 
spirometry tests, these patients should be rigorously 
screened by proper clinical tool like COPD population 
screening questionnaire before sending for pulmonary 
function test.6 In this line, US Preventive Services Task 
Force recommends against screening adults for COPD 
using spirometry following a systematic review of 
evidence of the benefits and harms and an assessment 
of the net benefit.7
A 2005 prospective cohort study in the United Kingdom 
assessed 125 participants with a previous clinical 
diagnosis of COPD.  When spirometry was used to confirm 
the COPD diagnosis, only 61 (49%) met diagnostic criteria. 
Of the remaining participants, 25 (20%) had reversible 
airway obstruction, 5 (4% ) had restrictive  obstruction, 
and 34 (27%) had normal spirometry.2 In our study, out 
of total clinically diagnosed COPD,  only 80 (23.7%) had 
airway obstruction, of which  50 (14.8%) had irreversible 
and 30 (8.9%) had reversible airway obstruction. The 
number of patient with normal spirometry in our study 
was 258 (76.3%) in contrast to 34 (27%) in a cohort 
study mentioned above.2 This raises the possibility of 
many patients having spirometry unnecessarily. In yet 
another cohort study, 184 of the 597 participants had a 
clinical diagnosis of chronic bronchitis or emphysema; 89 
(48%) of the 184 were confirmed as having COPD with 
spirometry, while 95 (52%) did not meet the criteria for 
COPD.3 This shows that not only in our study but in other 
parts of the world also many COPD patients are sent for 
spirometry unnecessarily.
Our study also highlighted the statistically significant 
difference between FEV1/FVC and FEV1 for normal, 
reversible and irreversible obstruction after controlling 
the possible confounders like age, sex and smoking 
status. So, spirometry can be used as a very good tool for 
diagnosis, grading and ongoing management of disease.
CONCLUSIONS
Clinical diagnosis of COPD needs to be confirmed by 
spirometry for ongoing management. It should however 
not be used for screening purpose. Other better tools like 
COPD questionnaire should be evaluated for screening 
tool. 
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